Current
$45.98B
5-Year Average
$43.13B
All-Time High
$61.85B
All-Time Low
$831.45M
Market cap daily chart for IDEXX Laboratories (IDXX)
Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days
Market Cap growth chart for IDEXX Laboratories (IDXX) from 1991 to 2026
Latest: -15.7%
Market Cap history table for IDEXX Laboratories (IDXX) from 1991 to 2026
| 2026 | $45.98B | -15.7% | −$8.59B | ||
| 2025 | $54.58B | +58.6% | +$20.16B | ||
| 2024 | $34.42B | -26.2% | −$12.19B | ||
| 2023 | $46.61B | +35.1% | +$12.10B | ||
| 2022 | $34.51B | -39.5% | −$22.49B | ||
| 2021 | $57.00B | +31.5% | +$13.65B | ||
| 2020 | $43.35B | +89.6% | +$20.49B | ||
| 2019 | $22.86B | +38.9% | +$6.40B | ||
| 2018 | $16.46B | +17.5% | +$2.45B | ||
| 2017 | $14.01B | +31.4% | +$3.35B | ||
| 2016 | $10.66B | +56.1% | +$3.83B | ||
| 2015 | $6.83B | -9.2% | −$696.04M | ||
| 2014 | $7.52B | +31.0% | +$1.78B | ||
| 2013 | $5.74B | +10.2% | +$531.20M | ||
| 2012 | $5.21B | +16.3% | +$731.03M | ||
| 2011 | $4.48B | +8.7% | +$357.48M | ||
| 2010 | $4.12B | +27.1% | +$879.22M | ||
| 2009 | $3.24B | +44.4% | +$997.51M | ||
| 2008 | $2.25B | -40.6% | −$1.53B | ||
| 2007 | $3.78B | +44.6% | +$1.17B | ||
| 2006 | $2.61B | +6.6% | +$161.93M | ||
| 2005 | $2.45B | +25.4% | +$496.96M | ||
| 2004 | $1.95B | +17.5% | +$291.44M | ||
| 2003 | $1.66B | +44.5% | +$511.72M | ||
| 2002 | $1.15B | +16.6% | +$163.58M | ||
| 2001 | $987.59M | +24.4% | +$193.80M | ||
| 2000 | $793.78M | +23.8% | +$152.71M | ||
| 1999 | $641.07M | -37.3% | −$381.37M | ||
| 1998 | $1.02B | +70.3% | +$421.94M | ||
| 1997 | $600.50M | -15.1% | −$106.49M | ||
| 1996 | $706.99M | -14.7% | −$122.00M | ||
| 1995 | $828.98M | +177.0% | +$529.73M | ||
| 1994 | $299.25M | +12.4% | +$33.00M | ||
| 1993 | $266.25M | +144.7% | +$157.45M | ||
| 1992 | $108.80M | +95.6% | +$53.18M | ||
| 1991 | $55.62M | — | — |
- 2026$45.98B-15.7%
- 2025$54.58B+58.6%
- 2024$34.42B-26.2%
- 2023$46.61B+35.1%
- 2022$34.51B-39.5%
- 2021$57.00B+31.5%
- 2020$43.35B+89.6%
- 2019$22.86B+38.9%
- 2018$16.46B+17.5%
- 2017$14.01B+31.4%
- 2016$10.66B+56.1%
- 2015$6.83B-9.2%
- 2014$7.52B+31.0%
- 2013$5.74B+10.2%
- 2012$5.21B+16.3%
- 2011$4.48B+8.7%
- 2010$4.12B+27.1%
- 2009$3.24B+44.4%
- 2008$2.25B-40.6%
- 2007$3.78B+44.6%
- 2006$2.61B+6.6%
- 2005$2.45B+25.4%
- 2004$1.95B+17.5%
- 2003$1.66B+44.5%
- 2002$1.15B+16.6%
- 2001$987.59M+24.4%
- 2000$793.78M+23.8%
- 1999$641.07M-37.3%
- 1998$1.02B+70.3%
- 1997$600.50M-15.1%
- 1996$706.99M-14.7%
- 1995$828.98M+177.0%
- 1994$299.25M+12.4%
- 1993$266.25M+144.7%
- 1992$108.80M+95.6%
- 1991$55.62M—
Market Cap values are taken from IDEXX Laboratories's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's latest reported market cap is $45.33B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2026 fiscal year, IDEXX Laboratories (IDXX) reported market cap of $45.98B – declined 15.7% year-over-year.
Through 2021–2026 (5 years), IDEXX Laboratories market cap delivered a -4.2% annualised rate; with a net decline across the window.
IDEXX Laboratories market cap peaked at $57.00B in 2021; the latest annual figure is $45.98B in 2026 (19.3% below peak).
$57.00B stands as the all-time-high annual market cap, posted in 2021, against a low of $55.62M during 1991.
IDEXX Laboratories Market Cap by Year
IDEXX Laboratories Market Cap 2026: $45.98B
IDEXX Laboratories posted market cap of $45.98B in 2026, declined 15.7% below 2025.
IDEXX Laboratories Market Cap 2025: $54.58B
In 2025, IDEXX Laboratories reported market cap of $54.58B, surged 58.6% from 2024.
IDEXX Laboratories Market Cap 2024: $34.42B
IDEXX Laboratories market cap in 2024 was $34.42B, declined 26.2% below 2023.
IDEXX Laboratories Market Cap 2023: $46.61B
2023's market cap for IDEXX Laboratories came in at $46.61B, surged 35.1% from 2022.
IDEXX Laboratories Market Cap 2022: $34.51B
IDEXX Laboratories market cap in 2022 was $34.51B.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by Market Cap
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest market cap
| $1.06T | |
| $567.28B | |
| $391.50B | |
| $373.28B | |
| $283.78B | |
| $274.92B | |
| $195.17B | |
| $189.18B |
- $1.06T
- $567.28B
- $391.50B
- $373.28B
- $283.78B
- $274.92B
- $195.17B
- $189.18B
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation